Jayda Keefer Name match only — unverified

Consultant · activity score 5

5 IND-paid disbursements
$1,898
paid as individual · 2 payers
3y
activity span (2024-2026)

Network 2 of 2 connections

Jayda Keefer at the center; committees they're directly tied to radiate out. Blue = Democratic-leaning, red = Republican-leaning, grey = mixed / non-partisan. Hover a committee to reveal its derived connections (dashed amber) — other committees that share an officer or 3+ vendors, links no single filing shows. Drag handles to filter by time; slider on the right caps visible connections.

Loading network…
scroll to zoom · drag background to pan · drag node to move
View as list (top 20, mobile-friendly)
  1. GEORGIA REPUBLICAN PARTY INC. paid · $1K paid
  2. MIKE COLLINS FOR SENATE paid · $1K paid

Activity over time 3 year span

2024: 0 committee · 0 candidate · 1 IND-paid ($1K)202420252026: 0 committee · 0 candidate · 3 IND-paid ($1K)2026
Committee-officer role Candidate filing IND-paid disbursement

Top payers 2 committees · $1,898 total

Committee Payments Total
GEORGIA REPUBLICAN PARTY INC. 1 $1,000
MIKE COLLINS FOR SENATE 3 $898

Aggregated across all Schedule B IND payments to this name. Color: derived partisan lean of the paying committee (direct party_affiliation OR committee_partisan_lean.lean_score for super PACs).

Recent payments to this name last 4 · $1,898

DatePayerPurposeAmount
Mar 20, 2026 MIKE COLLINS FOR SENATE EXPENSE REIMBURSEMENT $378
Mar 9, 2026 MIKE COLLINS FOR SENATE EXPENSE REIMBURSEMENT $318
Feb 11, 2026 MIKE COLLINS FOR SENATE NO ITEMIZATION NECESSARY - MILEAGE REIMBURSEMENT $202
Sep 30, 2024 GEORGIA REPUBLICAN PARTY INC. FEA-PAYROLL $1,000

Disbursement rows where this name appears as the payee (schedule_b entity_tp='IND'). Name-matched, not identity-resolved — may include same-named individuals.

Geographic concentration 2 states

GA
1 payer cmte
WI
1 payer cmte

Composite of candidate filings (cand.state) + states of distinct payer committees. Surfaces where the operative is geographically active.